with IDA, regardless of etiology, moderate hypotension was reported in 0.2% of subjects receiving Feraheme administered as intravenous infusion for at least 15 minutes .Iron overloadExcessive therapy with parenteral iron may lead to excess storage of iron with a possibility of iatrogenic hemosiderosis...
The dosage is expressed in terms of mg of elemental iron, with each mL of Feraheme containing 30 mg of elemental iron. Evaluate the hematologic response (hemoglobin, ferritin, iron andtransferrinsaturation) at least one month following the second Feraheme infusion. The recommended Feraheme dose may...
Intravenous (IV) infusion is time consuming and is inconvenient in Peritoneal Dialysis (PD) patients self-treating at home. A new preparation of iron, ferumoxytol, is a carbohydrate-coated, paramagnetic iron oxide nanoparticle, which can be administered as a bolus intravenous injection, allowing ...
One of the major elements contributing to anemia in Chronic Kidney Disease (CKD) patients is iron deficiency. Iron supplementation in oral form is often not tolerated and ineffectively absorbed. Intravenous (IV) infusion is time consuming and is inconvenient in Peritoneal Dialysis (PD) patients sel...
Intravenous (IV) infusion is time consuming and isinconvenient in Peritoneal Dialysis (PD) patients self-treating at home. A newpreparation of iron, ferumoxytol, is a carbohydrate-coated, paramagnetic ironoxide nanoparticle, which can be administered as a bolus intravenous injection,allowing the PD ...
Materials and methods: In an IRB-approved retrospective study, changes in vitals/clinical status between baseline, during infusion, and 30 min post-infusion were analyzed in 3 groups: group 1 (3 mg/kg BF, 216 patients, age: 19.29 卤 11.71 years ranging from 2 months to 62 years), ...